Cytokine-induced killer (CIK) cells, successes and challenges : report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy
© 2024. The Author(s)..
On August 30, 2023, experts from Germany and abroad met to discuss the successes and challenges of cytokine-induced killer cell (CIK) therapy, that recently celebrated its 30th anniversary providing treatment for cancer. This first virtual conference was hosted by CIO Bonn, a certified Comprehensive Cancer Center (CCC) funded by German Cancer Aid (DKH). In addition to keynote speakers involved in CIK cell clinical trials or optimized preclinical models to improve this adoptive cell immunotherapy, more than 100 attendees from around the world also participated in this event. Initiatives to establish the International Society of CIK Cells (ISCC) and a stronger CIK cell network guiding preclinical research and future clinical trials were also announced.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Cancer immunology, immunotherapy : CII - 73(2024), 2 vom: 27. Jan., Seite 21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sharma, Amit [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Completed 29.01.2024 Date Revised 22.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00262-023-03605-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367704099 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367704099 | ||
| 003 | DE-627 | ||
| 005 | 20240222232421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240128s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00262-023-03605-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1302.xml |
| 035 | |a (DE-627)NLM367704099 | ||
| 035 | |a (NLM)38279995 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sharma, Amit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cytokine-induced killer (CIK) cells, successes and challenges |b report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.01.2024 | ||
| 500 | |a Date Revised 22.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a On August 30, 2023, experts from Germany and abroad met to discuss the successes and challenges of cytokine-induced killer cell (CIK) therapy, that recently celebrated its 30th anniversary providing treatment for cancer. This first virtual conference was hosted by CIO Bonn, a certified Comprehensive Cancer Center (CCC) funded by German Cancer Aid (DKH). In addition to keynote speakers involved in CIK cell clinical trials or optimized preclinical models to improve this adoptive cell immunotherapy, more than 100 attendees from around the world also participated in this event. Initiatives to establish the International Society of CIK Cells (ISCC) and a stronger CIK cell network guiding preclinical research and future clinical trials were also announced | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Cytokine-induced killer (CIK) cell therapy | |
| 650 | 4 | |a Immunotherapies | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 700 | 1 | |a Ren, Xiubao |e verfasserin |4 aut | |
| 700 | 1 | |a Rosato, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Sangiolo, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zibing |e verfasserin |4 aut | |
| 700 | 1 | |a Tettamanti, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Rettinger, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Fenix, Kevin Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a Sommaggio, Roberta |e verfasserin |4 aut | |
| 700 | 1 | |a Cappuzzello, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt-Wolf, Ingo G H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer immunology, immunotherapy : CII |d 1991 |g 73(2024), 2 vom: 27. Jan., Seite 21 |w (DE-627)NLM012922226 |x 1432-0851 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2024 |g number:2 |g day:27 |g month:01 |g pages:21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00262-023-03605-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2024 |e 2 |b 27 |c 01 |h 21 | ||